ELCORA ADVANCED MATERIALS CO (ERA.CA) Fundamental Analysis & Valuation

TSX-V:ERA • CA2844452029

Current stock price

0.32 CAD
-0.03 (-8.57%)
Last:

This ERA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ERA.CA Profitability Analysis

1.1 Basic Checks

  • ERA had negative earnings in the past year.
  • In the past year ERA has reported a negative cash flow from operations.
  • ERA had negative earnings in each of the past 5 years.
  • In the past 5 years ERA always reported negative operating cash flow.
ERA.CA Yearly Net Income VS EBIT VS OCF VS FCFERA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

  • The Return On Assets of ERA (-57.21%) is worse than 65.66% of its industry peers.
Industry RankSector Rank
ROA -57.21%
ROE N/A
ROIC N/A
ROA(3y)-70.13%
ROA(5y)-89.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ERA.CA Yearly ROA, ROE, ROICERA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 1K 1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ERA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ERA.CA Yearly Profit, Operating, Gross MarginsERA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800 -1K

0

2. ERA.CA Health Analysis

2.1 Basic Checks

  • ERA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ERA has about the same amount of shares outstanding.
  • The number of shares outstanding for ERA has been increased compared to 5 years ago.
  • The debt/assets ratio for ERA is higher compared to a year ago.
ERA.CA Yearly Shares OutstandingERA.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
ERA.CA Yearly Total Debt VS Total AssetsERA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -22.85, we must say that ERA is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ERA (-22.85) is worse than 76.48% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -22.85
ROIC/WACCN/A
WACC11.94%
ERA.CA Yearly LT Debt VS Equity VS FCFERA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M 8M

2.3 Liquidity

  • A Current Ratio of 0.05 indicates that ERA may have some problems paying its short term obligations.
  • The Current ratio of ERA (0.05) is worse than 85.16% of its industry peers.
  • ERA has a Quick Ratio of 0.05. This is a bad value and indicates that ERA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ERA has a Quick ratio of 0.05. This is amonst the worse of the industry: ERA underperforms 85.03% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
ERA.CA Yearly Current Assets VS Current LiabilitesERA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M

0

3. ERA.CA Growth Analysis

3.1 Past

  • ERA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.06%, which is quite impressive.
  • ERA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)22.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.86%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ERA.CA Yearly Revenue VS EstimatesERA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 20K 40K 60K 80K 100K

0

4. ERA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • ERA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ERA.CA Price Earnings VS Forward Price EarningsERA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ERA.CA Per share dataERA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.02 -0.04 -0.06 -0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. ERA.CA Dividend Analysis

5.1 Amount

  • No dividends for ERA!.
Industry RankSector Rank
Dividend Yield 0%

ERA.CA Fundamentals: All Metrics, Ratios and Statistics

ELCORA ADVANCED MATERIALS CO

TSX-V:ERA (4/1/2026, 7:00:00 PM)

0.32

-0.03 (-8.57%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-27
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.6%
Ins Owner ChangeN/A
Market Cap11.45M
Revenue(TTM)N/A
Net Income(TTM)-1.12M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.08
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -57.21%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-70.13%
ROA(5y)-89.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -22.85
F-Score2
WACC11.94%
ROIC/WACCN/A
Cap/Depr(3y)437.76%
Cap/Depr(5y)498.68%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.74%
OCF growth 3YN/A
OCF growth 5YN/A

ELCORA ADVANCED MATERIALS CO / ERA.CA Fundamental Analysis FAQ

What is the fundamental rating for ERA stock?

ChartMill assigns a fundamental rating of 0 / 10 to ERA.CA.


Can you provide the valuation status for ELCORA ADVANCED MATERIALS CO?

ChartMill assigns a valuation rating of 0 / 10 to ELCORA ADVANCED MATERIALS CO (ERA.CA). This can be considered as Overvalued.


How profitable is ELCORA ADVANCED MATERIALS CO (ERA.CA) stock?

ELCORA ADVANCED MATERIALS CO (ERA.CA) has a profitability rating of 0 / 10.


How financially healthy is ELCORA ADVANCED MATERIALS CO?

The financial health rating of ELCORA ADVANCED MATERIALS CO (ERA.CA) is 0 / 10.